日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial

Selpercatinib治疗RET融合阳性非小细胞肺癌:LIBRETTO-001 I/II期试验的最终安全性和有效性,包括总生存期

Gautschi, Oliver; Park, Keunchil; Solomon, Benjamin J; Tomasini, Pascale; Loong, Herbert H; De Braud, Filippo; Goto, Koichi; Peterson, Patrick; Barker, Scott; Liming, Katherine; Oxnard, Geoffrey R; Frimodt-Moller, Bente; Drilon, Alexander

Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time

LIBRETTO-001 研究显示,selpercatinib 治疗 RET 激活的晚期实体瘤具有长期安全性:不良事件随时间推移呈现不同的模式。

Raez, Luis E; Massey, Ashish C; Barker, Scott S; Peterson, Patrick M; Liming, Katherine; Pennell, Nathan A

Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

Selpercatinib治疗RET融合阳性非小细胞肺癌患者:来自注册性LIBRETTO-001 I/II期试验的最新安全性和有效性数据

Drilon, Alexander; Subbiah, Vivek; Gautschi, Oliver; Tomasini, Pascale; de Braud, Filippo; Solomon, Benjamin J; Shao-Weng Tan, Daniel; Alonso, Guzmán; Wolf, Jürgen; Park, Keunchil; Goto, Koichi; Soldatenkova, Victoria; Szymczak, Sylwia; Barker, Scott S; Puri, Tarun; Bence Lin, Aimee; Loong, Herbert; Besse, Benjamin

Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001

一线塞帕替尼与标准疗法在RET激活癌症患者中的疗效比较:LIBRETTO-001研究的探索性患者间分析

De Braud, Filippo; Deschler-Baier, Barbara; Morris, John C 3rd; Worden, Francis; Han, Yimei; Kiiskinen, Urpo; Jen, Min-Hua; Barker, Scott S; Szymczak, Sylwia; Gilligan, Adrienne M

An in vitro toolbox to accelerate anti-malarial drug discovery and development

加速抗疟药物发现和开发的体外工具箱

Susan A Charman, Alice Andreu, Helena Barker, Scott Blundell, Anna Campbell, Michael Campbell, Gong Chen, Francis C K Chiu, Elly Crighton, Kasiram Katneni, Julia Morizzi, Rahul Patil, Thao Pham, Eileen Ryan, Jessica Saunders, David M Shackleford, Karen L White, Lisa Almond, Maurice Dickins, Dennis A

Operative versus non-operative treatment of humeral shaft fractures: A systematic review

肱骨干骨折的手术治疗与非手术治疗:系统评价

Sargeant, Harry William; Farrow, Luke; Barker, Scott; Kumar, Kapil

Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology

肿瘤靶向和生物制剂随机临床试验中无进展生存期与总生存期的关系

Hess, Lisa M; Brnabic, Alan; Mason, Oksana; Lee, Pablo; Barker, Scott

Incidence and Management of Olaratumab Infusion-Related Reactions

Olaratumab输注相关反应的发生率及处理

Van Tine, Brian A; Govindarajan, Rangaswamy; Attia, Steven; Somaiah, Neeta; Barker, Scott S; Shahir, Ashwin; Barrett, Emily; Lee, Pablo; Wacheck, Volker; Ramage, Samuel C; Tap, William D

Quantitative in situ analysis of FoxP3+ T regulatory cells on transplant tissue using laser scanning cytometry

利用激光扫描细胞术对移植组织上的FoxP3+ T调节细胞进行定量原位分析

Takahashi, Hidenori; Ruiz, Phillip; Ricordi, Camillo; Delacruz, Victor; Miki, Atsushi; Mita, Atsuyoshi; Misawa, Ryosuke; Barker, Scott; Burke, George W; Tzakis, Andreas G; Ichii, Hirohito

Prolactin supplementation to culture medium improves beta-cell survival.

在培养基中添加催乳素可提高β细胞的存活率

Yamamoto Toshiyuki, Mita Atsuyoshi, Ricordi Camillo, Messinger Shari, Miki Atsushi, Sakuma Yasunaru, Timoneri Francesca, Barker Scott, Fornoni Alessia, Molano R Damaris, Inverardi Luca, Pileggi Antonello, Ichii Hirohito